Incidence and Risk Factors of Osteonecrosis of Femoral Head in Multiple Myeloma Patients Undergoing Dexamethasone-Based Regimens.

Xinjie Wu Chuanying Geng Wei Sun Mingsheng Tan

Published in: BioMed research international (2020)

The overall incidence of ONFH in MM patients treated with DBRs is 6.7%, and 4 risk factors are confirmed including male, younger age, cumulative dose of dexamethasone, and hyperlipidemia in our study.

Keyphrases

risk factors
patients undergoing
multiple myeloma
high dose
low dose
high fat diet
adipose tissue